Disease mutations of human α3 Na(+)/K(+)-ATPase define extracellular Na(+) binding/occlusion kinetics at ion binding site III

人类α3 Na(+)/K(+)-ATPase的疾病突变决定了离子结合位点III处细胞外Na(+)的结合/阻断动力学。

阅读:1

Abstract

Na(+)/K(+)-ATPase, which creates transmembrane electrochemical gradients by exchanging 3 Na(+) for 2 K(+), is central to the pathogenesis of neurological diseases such as alternating hemiplegia of childhood. Although Na(+)/K(+)-ATPase has 3 distinct ion binding sites I-III, the difficulty of distinguishing ion binding events at each site from the others hinders kinetic study of these transitions. Here, we show that binding of Na(+) at each site in the human α3 Na(+)/K(+)-ATPase can be resolved using extracellular Na(+)-mediated transient currents. When Na(+)/K(+)-ATPase is constrained to bind and release only Na(+), three kinetic components: fast, medium, and slow, can be isolated, presumably corresponding to the protein dynamics associated with the binding (or release depending on the voltage step direction) and the occlusion (or deocclusion) of each of the 3 Na(+). Patient-derived mutations of residues which coordinate Na(+) at site III exclusively impact the slow component, demonstrating that site III is crucial for deocclusion and release of the first Na(+) into the extracellular milieu. These results advance understanding of Na(+)/K(+)-ATPase mutation pathogenesis and provide a foundation for study of individual ions' binding kinetics.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。